Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Mesenchymal stem cells (MSCs) have the ability to migrate into tumors and therefore are potential vehicles for the therapy of malignant diseases. In this study, we investigated the use of umbilical cord blood mesenchymal stem cells (UCB-MSCs) as carriers for a constant source of transgenic LIGHT (TNFSF14) to target tumor cells in vivo.
Lentiviral vectors carrying LIGHT genes were constructed, producing viral particles with a titer of 2 × 108 TU/L. Fourteen days after UCB-MSCs transfected by LIGHT gene packaged lentivirus had been injected into mouse gastric cancer models, the expression levels of LIGHT mRNA and protein were detected by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Then the tumors’ approximate volumes were measured.
The treatment with MSC-LIGHT demonstrated a strong suppressive effect on tumor growth compared to treatment with MSC and NaCl (p < 0.001). Examination of pathological sections of the tumor tissues showed that the areas of tumor necrocis in the MSC-LIGHT group were larger than those in the MSC group. Moreover, we found that MSCs with LIGHT were able to significantly induce apoptosis of tumor cells. The expression levels of LIGHT mRNA and protein were significantly higher in the UCB-MSCs with the LIGHT gene than the levels in UCB-MSCs (p < 0.001).
These results suggest that UCB-MSCs carrying the LIGHT gene have the potential to be used as effective delivery vehicles in the treatment of gastric cancers.
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. CrossRef
- Macdonald JS. Gastric cancer—new therapeutic options. N Engl J Med. 2006;355:76–7. CrossRef
- Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT. Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells. 2003;21:389–404. CrossRef
- Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 2000;97:12846–51. CrossRef
- Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res. 2002;62:3603–8.
- Miletic H, Fischer Y, Litwak S, Giroglou T, Waerzeggers Y, et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther. 2007;15:1373–81. CrossRef
- Nakamizo A, Marini F, Amano T, Khan A, Studeny M, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005;65:3307–18.
- Van Damme A, Vanden Driessche T, Collen D, Chuah MK. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther. 2002;2:195–209. CrossRef
- Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294–301. CrossRef
- Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008;23:9614–23. CrossRef
- Bhoopathi P, Chetty C, Gogineni VR, Gujrati M, Dinh DH, Rao JS, Lakka SS. MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors. Gene Ther. 2011;7:692–701. CrossRef
- Kim SM, Kim DS, Jeong CH, Kim DH, Kim JH, Jeon HB, Kwon SJ, Jeun SS, Yang YS, Oh W, Chang JW. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas. Biochem Biophys Res Commun. 2011;4:741–6. CrossRef
- Park SA, Ryu CH, Kim SM, Lim JY, Park SI, Jeong CH, Jun JA, Oh JH, Park SH, Oh W, Jeun SS. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol. 2011;1:97–103.
- Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, et al. LIGHT, a new member of the LIGHT superfamily, and lymphotoxin are ligands for herpesvirus entry mediator. Immunity. 1998;8:21–30. CrossRef
- Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest. 1998;102:1142–51. CrossRef
- Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, et al. LIGHT, a LIGHT-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol. 2000;164:4105–10.
- Shi G, Luo H, Wan X, Salcedo TW, Zhang J, et al. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood. 2002;100:3279–86. CrossRef
- Wan X, Zhang J, Luo H, Shi G, Kapnik E, et al. A LIGHT family member LIGHT transduces costimulatory signals into human T cells. J Immunol. 2002;169:6813–21.
- Shi G, Mao J, Yu G, Zhang J, Wu J. Tumor vaccine based on cell surface expression of DcR3/TR6. J Immunol. 2005;174:4727–35.
- Harrop JA, Reddy M, Dede K, Brigham-Burke M, Lyn S, et al. Antibodies to TR2 (herpesvirus entry mediator), a new member of the LIGHT receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol. 1998;161:1786–94.
- Tamada K, Shimozaki K, Chapoval AI, Zhu G, Sica G, et al. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med. 2000;6:283–9. CrossRef
- Lu FZ, Fujino M, Kitazawa Y, Uyama T, Hara Y, Funeshima N, Jiang JY, Umezawa A, Li XK. Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood. J Lab Clin Med. 2005;146:271–8. CrossRef
- Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem. 1999;274:13733–6. CrossRef
- Morishige T, Yoshioka Y, Tanabe A, Yao X, Miuguchi H, et al. Comparison of the anti-tumor activity of native, secreted, and membrane-bound LIGHT in mouse tumor models. Int Immunopharmacol. 2010;10:26–33. CrossRef
- Hu G, Liu Y, Li H, Zhao D, Yang L, et al. Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect. Cell Mol Immunol. 2010;7:296–305. CrossRef
- Loeffler M, Le’Negrate G, Krajewska M, Reed JC. Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Natl Acad Sci USA. 2007;104:12879–83. CrossRef
- Yu P, Fu YX. Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev. 2008;19:285–94. CrossRef
- Fan Z, Yu P, Wang Y, Wang Y, Fu ML, et al. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood. 2006;107:1342–51. CrossRef
- Rubinstein P, Rosenfeld RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81:679–1690.
- Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune Tsudal M, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004;11:1155–64. CrossRef
- Wolf D, Rumpold H, Koeck R, Gunsilius E. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2005;97:540–1. CrossRef
- Zhao BC, Wang ZJ, Ma HC, Han JG, Zhao B, et al. CXCR4/SDF-1 axis is involved in the lymph node metastasis of gastric carcinoma. World J Gastroenterol. 2011;19:2389–96. CrossRef
- Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells
Volume 16, Issue 2 , pp 155-166
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- LIGHT (TNFSF14)
- Gastric cancer
- Lentiviral vector
- Umbilical cord blood mesenchymal stem cells (UCB-MSCs)
- Industry Sectors
- Author Affiliations
- 1. Department of Central Laboratory, Qingdao Municipal Hospital, Qingdao, China
- 2. Center of Metabolic Disease Research, Nanjing Medical University, Nanjing, China
- 3. Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, China
- 4. Department of General Surgery, Qingdao Municipal Hospital, 5 Donghai Middle Road, Qingdao, 266071, China
- 5. Endoscopy Department, Tianjin Medical University Affiliated Cancer Hospital, Tianjin, China
- 6. Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, 32610-0275, USA
- 7. Department of Molecular and Cellular Biochemistry, Markey Cancer Center, University of Kentucky School of Medicine, BBSRB Room B336, 741 South Limestone, Lexington, KY, 40506-0509, USA